Improving Access to Improve Quality in an HMO
改善可及性以提高 HMO 质量
基本信息
- 批准号:7211830
- 负责人:
- 金额:$ 29.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-30 至 2008-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Provided by applicant): Background and Significance. In Crossing the Quality Chasm, the Institute of Medicine concludes that U.S. health care is plagued by low quality, and recommends that quality can be improved partly by creating "patient-centered" delivery systems offering "continuous access" to healthcare. Group Health Cooperative (GHC) has launched an Access Initiative to improve quality by increasing enrollee access to physicians and information through the following system reforms: health promotion information on the MyGroupHealth (MyGH) enrollee Web portal; patient-provider secure messaging through MyGH with physician financial incentives for messaging; advanced access to primary care; primary care system redesign to control costs; direct access to specialist physicians (removal of gatekeeping); changes in primary and specialty physician compensation; and Internet access for enrollees to their electronic medical records. The GHC reforms may benefit patients with multiple chronic conditions, based on the IOM recommendations. Aims. For the population of enrollees with type 2 diabetes mellitus continuously enrolled in Group Health between 1997-2006, aims are to: 1) Estimate the baseline prevalence and incidence of other chronic conditions between 1997-2006, emphasizing heart disease, hypertension, congestive heart failure and depression; 2) Estimate utilization of Web-based patient-provider secure messaging, electronic medical records, and health promotion information; 3) Compare provider visits, hospital use, and costs before vs. after the Initiative; and 4) Compare continuity and quality of care before vs. after the Initiative.
Study Design. In Aims 1 and 2, a longitudinal cohort design will be used to estimate baseline, prevalence and incidence of type 2 diabetes, and to estimate enrollee utilization of the Initiative's components for three mutually-exclusive cohorts in GHC's population of 16,561 continuously enrolled adults > age 18 with diabetes: 1) Prevalence cohort of enrollees who had diabetes and one or more other chronic conditions in 1997; 2) Incidence cohort of enrollees who developed one or more other chronic conditions in 1998-2006; and 3) a Diabetes only cohort with no other chronic conditions 1997-2006. In Aims 3-4, single interrupted time series design will be used to compare utilization, cost and quality before vs. after the Initiative.
Population. Group Health enrollees who are continuously enrolled 1997-2006 with diabetes in western Washington state (approximately N= 16,561). Measures. Enrollee use of secure messaging and MyGH, outpatient and hospital use, ER use, costs and quality of care.
Data Sources. Group Health automated data bases.
Analyses. Descriptive, bivariate, regression, and time series analyses will be performed.
描述(由申请人提供):背景和意义。在《跨越质量鸿沟》一书中,美国医学研究所得出结论,美国的医疗保健受到低质量的困扰,并建议通过创建“以患者为中心”的交付系统,提供“持续的”医疗保健服务,可以在一定程度上提高质量。集团健康合作社(GHC)发起了一项获取倡议,通过以下系统改革增加注册者获得医生和信息的机会,从而提高质量:“我的集团健康”(MyGroupHealth)注册者门户网站上的健康促进信息;通过MyGH实现患者与提供者之间的安全信息传递,并为信息传递提供医生经济奖励;提前获得初级保健;重新设计初级保健系统以控制费用;直接接触专科医生(取消门卫);初级医师和专科医师薪酬的变化;以及为注册者提供互联网访问他们的电子医疗记录。根据IOM的建议,GHC改革可能会使患有多种慢性疾病的患者受益。目标。对1997-2006年连续纳入组健康的2型糖尿病患者,目的是:1)估计1997-2006年期间其他慢性疾病的基线患病率和发病率,重点是心脏病、高血压、充血性心力衰竭和抑郁症;2)评估基于web的患者-提供者安全信息、电子病历和健康促进信息的利用率;3)比较计划实施前后的提供者访问量、医院使用情况和费用;4)比较“倡议”前后护理的连续性和质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David E Grembowski其他文献
David E Grembowski的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David E Grembowski', 18)}}的其他基金
Diffusion of Anticipatory Guidance to Prevent ECC Disease Transmission: Secondary
预防 ECC 疾病传播的预期指导的传播:次要
- 批准号:
8242677 - 财政年份:2011
- 资助金额:
$ 29.91万 - 项目类别:
Diffusion of Anticipatory Guidance to Prevent ECC Disease Transmission: Secondary
预防 ECC 疾病传播的预期指导的传播:次要
- 批准号:
8029192 - 财政年份:2011
- 资助金额:
$ 29.91万 - 项目类别:
STATINS AND ACE INHIBITORS IN ADULTS WITH DIABETES AND COMORBID CONDITIONS
他汀类药物和 ACE 抑制剂用于患有糖尿病和合并症的成人
- 批准号:
8015132 - 财政年份:2010
- 资助金额:
$ 29.91万 - 项目类别:
Diabetes Mellitus, Comorbid Conditions and Mortality
糖尿病、合并症和死亡率
- 批准号:
7539030 - 财政年份:2008
- 资助金额:
$ 29.91万 - 项目类别:
Improving Access to Improve Quality in an HMO
改善可及性以提高 HMO 质量
- 批准号:
7287397 - 财政年份:2006
- 资助金额:
$ 29.91万 - 项目类别:
Race/Ethnicity, Socioeconomic Status and Oral Health
种族/民族、社会经济地位和口腔健康
- 批准号:
7129714 - 财政年份:2006
- 资助金额:
$ 29.91万 - 项目类别:
Linking Mother and Child Access to Dental Care
将母亲和儿童获得牙科护理联系起来
- 批准号:
6752889 - 财政年份:2003
- 资助金额:
$ 29.91万 - 项目类别:
Health Services Research Training at the University of Washington
华盛顿大学卫生服务研究培训
- 批准号:
8690071 - 财政年份:2003
- 资助金额:
$ 29.91万 - 项目类别:
Linking Mother and Child Access to Dental Care
将母亲和儿童获得牙科护理联系起来
- 批准号:
6571336 - 财政年份:2003
- 资助金额:
$ 29.91万 - 项目类别:
Linking Mother and Child Access to Dental Care
将母亲和儿童获得牙科护理联系起来
- 批准号:
6891382 - 财政年份:2003
- 资助金额:
$ 29.91万 - 项目类别:
相似海外基金
Phase Ib/II study of safety and efficacy of EZH2 inhibitor, tazemetostat, and PD-1 blockade for treatment of advanced non-small cell lung cancer
EZH2 抑制剂、他泽美司他和 PD-1 阻断治疗晚期非小细胞肺癌的安全性和有效性的 Ib/II 期研究
- 批准号:
10481965 - 财政年份:2024
- 资助金额:
$ 29.91万 - 项目类别:
睡眠時無呼吸症と睡眠時ブラキシズムのcomorbidityを成立させる病態生理機構の解明
阐明睡眠呼吸暂停和睡眠磨牙症并存的病理生理机制
- 批准号:
24K02631 - 财政年份:2024
- 资助金额:
$ 29.91万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
- 批准号:
10838849 - 财政年份:2024
- 资助金额:
$ 29.91万 - 项目类别:
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
- 批准号:
10825287 - 财政年份:2024
- 资助金额:
$ 29.91万 - 项目类别:
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
胆红素分解代谢诱导纤溶酶原激活剂抑制剂 1 (PAI-1) 恶化代谢功能障碍
- 批准号:
10750132 - 财政年份:2024
- 资助金额:
$ 29.91万 - 项目类别:
Multimorbidity in Children and Youth Across the Life-course (MY LIFE): A Long-term Follow-up
儿童和青少年一生中的多重疾病(我的一生):长期随访
- 批准号:
483695 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Operating Grants
ARISTOTELES - Applying ARtificial Intelligence to Define clinical trajectorieS for personalized predicTiOn and early deTEctiOn of comorbidiTy and muLtimorbidiTy pattErnS
亚里士多德 - 应用人工智能定义临床轨迹,以实现个性化预测以及合并症和多发病模式的早期检测
- 批准号:
10103153 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
EU-Funded
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations
多种族人群中 AD 的中心连锁纵向外周生物标志物
- 批准号:
10555723 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别:
Simulating the Spread and Control of Multiple MDROs Across a Network of Different Nursing Homes
模拟多个 MDRO 在不同疗养院网络中的传播和控制
- 批准号:
10549492 - 财政年份:2023
- 资助金额:
$ 29.91万 - 项目类别: